The Patent Finder

Biotempt B.V.

1 patent currently held · Updated Nov 19, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Sep 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 19, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 1 of 1

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,795,226Control of radiation injury
In force
 · USPTO record
In forceUSPTO record
Also on record, not counted in the 1: 10 lapsed for an unpaid fee · 6 ended at full term · 3 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 2 abandoned · 11 no status recorded

Showing 1 to 10 of 19, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/960,532Peptide Modulators of the Interaction Between Human C-Peptide and Human Elastin Receptor for Therapeutic UseNov 26, 2024Pending
18/310,188Peptide Modulators of the Interaction Between Human C-Peptide and Human Elastin Receptor for Therapeutic UseMay 1, 2023Abandoned
18/698,512Angiogenic Control, Preferably Combined with Glycaemic ControlOct 5, 2022Pending
18/548,845Chemotactic Autophagy-Inhibiting Peptide, Compositions and Methods Related TheretoMar 2, 2022Pending
18/029,174Autophagy-Inhibiting Peptide and Organic Acid Salt Thereof Addressing Issues of Vascular PermeabilitySep 29, 2021Pending
17/995,692Methods and Means for Modifying Hemodynamics in InfectionsApr 6, 2021Pending
17/639,018Q-Er PeptideAug 28, 2020Pending
16/483,317Peptide Modulators of the Interaction Between Human C-Peptide and Human Elastin Receptor for Therapeutic UseFeb 5, 2018Abandoned
12/803,689Jul 1, 2010No status recorded
12/802,967Jun 16, 2010No status recorded
10 of 19 applications shown.
Pro members see all 19 published applications.
Pro members: see all 19 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited